Understanding the MDX Test: What Your Results Mean for Duchenne Muscular Dystrophy
The MDX percent blood test quantifies dystrophin protein in blood, aiding diagnosis and monitoring of Duchenne muscular dystrophy (DMD)—an X-linked recessive disorder causing progressive muscle degeneration.
Interpretation
- Normal dystrophin levels: Rules out DMD.
- Low/absent dystrophin: Consistent with DMD. Lower levels → more severe phenotype.
- Intermediate levels: Seen in Becker muscular dystrophy (BMD) or female carriers.
Clinical Utility
- Diagnosis: Supports genetic testing (gold standard).
- Severity correlation: Dystrophin % predicts age of loss of ambulation, cardiac involvement.
- Treatment monitoring: Tracks response to exon-skipping, gene therapy, corticosteroids.
- Carrier detection: Female carriers may show 30–70% dystrophin.
Limitations
- Not standalone; requires genetic confirmation (MLPA, sequencing).
- Blood dystrophin may not perfectly reflect muscle levels.
- Interpretation by neuromuscular specialist essential.
Medical Billing - Related Articles
- Understanding Medical Codes: A Comprehensive Guide
- Medical Certificate Template & Guide: Creating a Legally Sound Document
- VD (Venereal Disease): Definition, Examples, and Modern Terminology
- Can Paying the Hospital Directly Remove Medical Bills from Collections?
- Managing Uninsured Patients: A Protocol for Healthcare Practices
- Doctor Listed In-Network But Isn't: Your Bill Responsibility & Rights
- CPT 99284: Emergency Department Visit - Moderate Complexity
